Compounds for the treatment of female sexual dysfunction

Details for Australian Patent Application No. 2005201482 (hide)

Owner Pfizer Inc.

Inventors Maw, Graham Nigel; Wayman, Christopher Peter

Agent Spruson & Ferguson

Pub. Number AU-A-2005201482

Parent 781403

Filing date 7 April 2005

Wipo publication date 5 May 2005

International Classifications

A61K 031/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

G01N 033/573 Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

A61K 031/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 031/553 - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 015/02 Drugs for genital or sexual disorders

A61K 031/433 - Thiadiazoles

A61K 031/197

A61K 038/12 Medicinal preparations containing peptides - Cyclic peptides

A61K 031/44 - Non-condensed pyridines

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 031/34 - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/438 - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 031/437

A61K 031/548 - having two or more sulfur atoms in the same ring

A61K 031/499 - Spiro-condensed pyrazines or piperazines

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

21 April 2005 Complete Application Filed

5 May 2005 Application Open to Public Inspection

  Published as AU-A-2005201482

24 November 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201483-CDCV

2005201481-Methods for treating neurodegenerative disorders using aspartyl protease inhibitors